GSK
761 hedge funds and large institutions have $8.05B invested in GSK in 2016 Q4 according to their latest regulatory filings, with 109 funds opening new positions, 211 increasing their positions, 327 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $9.13B → $8.05B (-$1.07B)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
35% less repeat investments, than reductions
Existing positions increased: 211 | Existing positions reduced: 327
Holders
761
Holding in Top 10
7
Calls
$154M
Puts
$137M
Top Buyers
| 1 | +$88.8M | |
| 2 | +$87.8M | |
| 3 | +$83M | |
| 4 |
D.E. Shaw & Co
New York
|
+$64.2M |
| 5 |
Millennium Management
New York
|
+$49.2M |
Top Sellers
| 1 | -$195M | |
| 2 | -$83.5M | |
| 3 | -$72M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$45.9M |
| 5 |
Neuberger Berman Group
New York
|
-$32.9M |